IM Cannabis Corp.
As of Oct 22, 2026, IM Cannabis is in Stage 4, the downtrend phase, now in week 53 (since Oct 7, 2025). It closed at $0.93, 98.4% below its 52-week high and below its 200-day average, which is falling.
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is IMCC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
IMCC among Drug Manufacturers - Specialty & Generic81st of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …81 | IMCC | Stage 4 · wk 53 | 3 | −68.2% |
IM Cannabis: quick answers
What stage is IM Cannabis in?
As of Oct 22, 2026, IM Cannabis (IMCC) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 7, 2025 and is in week 53. What the four stages mean
Is IM Cannabis in an uptrend?
No. IM Cannabis is in a Stage 4 downtrend. It trades 92.5% below its 200-day average, which is falling.
How far is IM Cannabis from its 52-week high?
IM Cannabis closed at $0.93 on Oct 22, 2026, 98.4% below its 52-week high of $56.40. Its 52-week low is $0.93.
How has IM Cannabis performed over the past year?
As of Oct 22, 2026, IM Cannabis is down 98.4% over the past year and down 97.9% so far in 2026.
Which sector and industry is IM Cannabis in?
IM Cannabis is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.